Labroots

CliniMACS Prodigy® Adherent Cell Culture System: Automated, large-scale, and GMP-compliant manufacturing of various stem cells and their derivatives

Regenerative medicine has become a key focus worldwide and the number of stem cell-based clinical trials are rapidly increasing every year. Yet, large-scale and GMP-compliant stem cell manufacturing ...
Labroots

CliniMACS Prodigy® Adherent Cell Culture System: Pluripotent stem cell expansion & differentiation in an automated, closed system

Regenerative medicine has become a key focus worldwide and the number of stem cell, especially pluripotent stem cell (PSC)-based clinical trials are rapidly increasing every year. Yet, large-scale and ...
GEN

IsoPlexis and Miltenyi Report on Synergistic CAR-T Cell Technologies

IsoPlexis, which recently received an NCI grant, reports that it has published a technology note with Miltenyi Biotec in a co-marketing agreement. The tech note (“Getting the most out of your CAR-T ...
BizTimes

Froedtert & MCW-developed cancer therapy advances to phase II clinical trial

The CliniMACS Prodigy, a device designed to manufacture cellular products used in cell-based therapies. Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact ...